The Overall Survival of Patients With Unresectable HCC in Real-life

Humanity & Health Medical Group Limited

Status: Enrolling

Conditions: Hepatocellular Carcinoma

Study type: Observational

Funder types: Other

Identifiers

NCT03612726

APASL_HCC_2018V1

Details and patient eligibility

About

Liver cancer is the fifth most common cancer and the second most frequent cause of cancer-related death globally. Hepatocellular carcinoma represents about 90% of primary liver cancers and constitutes a major global health problem. The pattern of HCC occurrence shows a significant geographical imbalance, with the highest incidence rates in East Asia (more than 50% of the cases occurring in China).

The aim of this study is to investigate the overall survival (OS) of patients diagnosed with unresectable hepatocellular carcinoma under real-world practice conditions in Asia Pacific region.

Enrollment: 5,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with a diagnosis of unresectable hepatocellular carcinoma
• Able to comprehend and provide written informed consent in accordance with institutional guidelines.

Exclusion criteria

• Patients not willing to participate and/or give their written informed consent.